Mannosylated liposomes for targeted gene delivery

Fansheng Kong; Fang Zhou; Linfu Ge; Ximin Liu; Wang, Yong
January 2012
International Journal of Nanomedicine;2012, Vol. 7, p1079
Academic Journal
No abstract available.


Related Articles

  • Novel possibilities of development and therapeutic applications of Liposomes. Kalyankar, T. M.; Khan, Mubeena; Rangari, Nalanda T.; Wagh, Vijay D. // Journal of Pharmacy Research;Aug2010, Vol. 3 Issue 8, p1880 

    Liposomes are one of the unique drug delivery system, which can be of potential use in controlling and targeting drug delivery. Liposomes are administered orally, topically and parentally as well as use in cosmetics and hair technologies, sustained release formulations, diagnostic purpose and as...

  • Ligation Strategies for Targeting Liposomal Nanocarriers. Marqués-Gallego, Patricia; de Kroon, Anton I. P. M. // BioMed Research International;2014, Vol. 2014, p1 

    Liposomes have been exploited for pharmaceutical purposes, including diagnostic imaging and drug and gene delivery. The versatility of liposomes as drug carriers has been demonstrated by a variety of clinically approved formulations. Since liposomes were first reported, research of liposomal...

  • Development of the Liposomes Entrapped Ultrasound Imaging Gas ("Bubble Liposomes") as Novel Gene Delivery Carriers. Suzuki, Ryo; Tanaka, Kumiko; Sawamura, Kaori; Takizawa, Tomoko; Utoguchi, Naoki; Negishi, Yoichi; Hagisawa, Kohsuke; Nishioka, Toshihiko; Maruyama, Kazuo // AIP Conference Proceedings;2006, Vol. 829 Issue 1, p568 

    Recently, microbubbles and ultrasound have been investigated with a view to improving the transfection efficiency of nonviral delivery systems for gene by cavitation. However, microbubbles had some problems in terms of stability and targeting ability. To solve these problems, we paid attention...

  • Evaluation of Drug Targeting Strategies and Liposomal Trafficking. Oku, Naoto; Tokudome, Yoshihiro; Asai, Tomohiro; Tsukada, Hideo // Current Pharmaceutical Design;Nov2000, Vol. 6 Issue 16, p1669 

    Liposomes, that are biodegradable and essentially non-toxic, can encapsulate both hydrophilic and hydrophobic materials, and are utilized as drug carriers for drug delivery systems (DDS). Recent progress in gene technology provides a novel modality of therapy for various diseases with a variety...

  • Development of Liposomal Bubbles with Perfluoropropane Gas as Gene Delivery Carriers. Maruyama, Kazuo; Suzuki, Ryo; Sawamura, Kaori; Takizawa, Tomoko; Utoguchi, Naoki; Negishi, Yoichi // AIP Conference Proceedings;2007, Vol. 911 Issue 1, p467 

    Liposomes have some advantages as drug, antigen and gene delivery carriers. Their size can be easily controlled and they can be modified to add a targeting function. Based on liposome technology, we developed novel liposomal bubbles (Bubble liposomes) containing the ultrasound imaging gas,...

  • In Vitro and In Vivo Effective Gene Delivery with Novel Liposomal Bubbles. Nishiie, Norihito; Suzuki, Ryo; Oda, Yusuke; Hirata, Keiichi; Taira, Yuichiro; Utoguchi, Naoki; Negishi, Yoichi; Maruyama, Kazuo // AIP Conference Proceedings;3/9/2010, Vol. 1215 Issue 1, p115 

    Microbubbles, which were ultrasound contrast agents, could improve the transfection efficiency by cavitation with ultrasound exposure. However, conventional microbubbles had some problems regarding size and targeting ability. To solve these problems, we paid attention to liposomes that had many...

  • Priprava i imunomodulacijska svojstva modificiranih peptidoglikanskih fragmenata. Ribić, R.; Tomić, S. // Kemija u Industriji;Jan2013, Vol. 62 Issue 1/2, p19 

    Immunostimulators, known also as adjuvants, are added to vaccines to accelerate, extend or amplify the specific immune reaction to a specific antigen. One well known class of immunomodulating compounds is based on muramylpeptides which are fragments of peptidoglycans, natural polymers that build...

  • Liposomal Drug Delivery Systems: An Update Review. Samad, Abdus; Sultana, Y.; Aqil, M. // Current Drug Delivery;Oct2007, Vol. 4 Issue 4, p297 

    The discovery of liposome or lipid vesicle emerged from self forming enclosed lipid bi-layer upon hydration; liposome drug delivery systems have played a significant role in formulation of potent drug to improve therapeutics. Recently the liposome formulations are targeted to reduce toxicity and...

  • Evaluation of Osteoclastogenesis via NFκB Decoy/mannosylated Cationic Liposome-Mediated Inhibition of Pro-inflammatory Cytokine Production from Primary Cultured Macrophages. Dinh, Thuy; Higuchi, Yuriko; Kawakami, Shigeru; Yamashita, Fumiyoshi; Hashida, Mitsuru // Pharmaceutical Research;Apr2011, Vol. 28 Issue 4, p742 

    Purpose: To explore the effect of NFκB activation in macrophages on osteoclastogenesis of bone marrow cells for potential application as a new type of therapy for preventing bone loss. Methods: Primary cultured macrophages and bone marrow cells were prepared from mice. As macrophage-targeted...

  • Immunoliposomes. Paszko, E.; Senge, M. O. // Current Medicinal Chemistry;Nov2012, Vol. 19 Issue 32, p5239 

    Since their discovery by Bangham about 50 years ago, liposomes have become promising tools in drug delivery systems. This has increased the therapeutic index of many drugs, and offers improved drug targeting and controlled release. In order to further improve the specificity of liposomes for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics